CHOP IBD Doctor Offers Reassuring News About COVID-19 Risk in Children With IBD

Published on in CHOP News

Andrew Grossman, MD Andrew Grossman, MD Pediatric inflammatory bowel disease (IBD) patients have a relatively low risk of severe COVID-19, even when receiving biologic and other immune-suppressive therapies, according to an analysis of two international databases. This analysis also shows that medication adherence is important.

Andrew B. Grossman, MD, from our Center for Pediatric Inflammatory Bowel Disease discusses the reassuring studies in this MedPageToday article.

 

Contact: Joey McCool Ryan, The Children’s Hospital of Philadelphia, 267-426-6070 or mccool@email.chop.edu